Search

everythinglearnresearchcommunity

for

Search:↓

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Effective treatments for severe alopecia areata are still lacking.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Early intervention and patient education are crucial for managing alopecia areata.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Regulatory T cells are essential for normal and improved wound healing in mice.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

People with alopecia areata have higher insulin resistance.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Permanent hair dye may cause total hair loss.

Retinol may affect immune responses in people with frequent skin boils.

Erdr1 could be a new marker for diagnosing hair loss.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Human skin can make serotonin and melatonin, which help protect and maintain it.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.